AxoGen, Inc. logo

AxoGen, Inc.

NASDAQ:AXGN

Overview | Financials
Company Name AxoGen, Inc.
Symbol AXGN
Currency USD
Price 15.64
Market Cap 688,289,812
Dividend Yield 0%
52-week-range 5.55 - 15.9
Industry Medical Devices
Sector Healthcare
CEO Ms. Karen Zaderej
Website https://www.axogeninc.com

An error occurred while fetching data.

About AxoGen, Inc.

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector,

Related Stocks

ADMA Biologics, Inc. logo

ADMA Biologics, Inc.

ADMA

17.4 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

52.91 USD

Akoya Biosciences, Inc. logo

Akoya Biosciences, Inc.

AKYA

2.49 USD

Protagonist Therapeutics, Inc. logo

Protagonist Therapeutics, Inc.

PTGX

41.49 USD

Sight Sciences, Inc. logo

Sight Sciences, Inc.

SGHT

3.57 USD

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI

1.56 USD

Repare Therapeutics Inc. logo

Repare Therapeutics Inc.

RPTX

1.32 USD

Agenus Inc. logo

Agenus Inc.

AGEN

2.83 USD

Financials

Numbers are in millions USD

Numbers are in millions USD